French
DeutschCannabidiphorol
 | |
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H34O2 |
| Molar mass | 342.523 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Cannabidiphorol, the heptyl-homologue of cannabidiol was identified as a natural phytocannabinoid and named cannabidiphorol (CBDP) in 2019.[1] It had previously been reported as a synthetic compound,[2] but was not identified as a natural product prior to 2019. Recently, CBDP has been gained popularity due to it being synthesized and available on a commercial level.[3]
Pharmacology
[edit]Pharmacodynamics
[edit]CBDP shows weak antagonism at both cannabinoid receptors (CB1 and CB2), similar to cannabidiol (CBD). CBD, however, exhibits stronger antagonism at CB2, reaching a 33% maximum response of SR144528 versus CBDP's 23%.[4]
Both cannabinoids act as weak agonists at the serotonin 5-HT1A receptor, contributing to potential anxiolytic effects.[4]
CBDP also shows weak agonism at the dopamine D2S receptor, with potential implications for mood regulation and addiction treatments.[4]
Unexpectedly, CBDP acts as a positive allosteric modulator (PAM) at the MOR, enhancing met-enkephalin signaling by 37%, potentially affecting pain perception.[4]
References
[edit]- ^ Citti C, Linciano P, Russo F, Luongo L, Iannotta M, Maione S, et al. (December 2019). "A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol". Scientific Reports. 9 (1): 20335. Bibcode:2019NatSR...920335C. doi:10.1038/s41598-019-56785-1. PMC 6937300. PMID 31889124.
- ^ US Abondoned 2012/172339, Makriyannis A, Nikas SP, Alapafuja SO, "Angiogenic resorcinol derivatives", published 5 July 2012, assigned to Northeastern University Boston.
- ^ Heredia M (27 May 2024). "What Is CBDP? Everything You Need To Know". herb.co. Retrieved 2024-09-13.
- ^ a b c d Haghdoost M, et al. (July 2024). "CBD Versus CBDP: Comparing In Vitro Receptor-Binding Activities". International Journal of Molecular Sciences. 25 (14): 7724. doi:10.3390/ijms25147724. PMC 11277192. PMID 39062976.